Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 2 2Phase NA 1Phase 4 1

Status

Terminated 2Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 17Sarcoma 11Breast 9Gastrointestinal 7Thoracic 6Other solid neoplasm 6Head & Neck 5CNS 4Tumor-Agnostic 3Gynecologic 3Dermatologic 2Lymphoid 1Endocrine 1

Conditions

Neoplasm Metastasis 2Neoplasms 1

Interventions

pembrolizumab 46Paclitaxel 46Gemcitabine 41Carboplatin 37Docetaxel 35Bevacizumab 27Cisplatin 25Irinotecan 22Nivolumab 20Fluorouracil 20Erlotinib Hydrochloride 18Pemetrexed 17Capecitabine 17Sorafenib 16Magnetic Resonance Spectroscopy 16Cetuximab 16Afatinib 16Leucovorin 15regorafenib 14olaparib 13Specimen Handling 13Oxaliplatin 13trametinib 12Biopsy 12130-nm albumin-bound paclitaxel 11eribulin 10atezolizumab 10epothilone B 9Radiotherapy 9Midazolam 9

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 1 × pazopanib × Tumor-Agnostic × Clear all
NCT01642017 2026-04-14

VOTRAGE

Institut Claudius Regaud

Phase 1 Terminated
18 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT02138526 2020-10-19

DIET

Radboud University Medical Center

Phase 1 Completed
78 enrolled
Tumor-Agnostic

Neoplasms

NCT01542047 2015-06-18

A Combination of Pazopanib and Carboplatin in Advanced Solid Malignancies

New Mexico Cancer Research Alliance

Phase 1 Terminated
3 enrolled
Tumor-Agnostic

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡